Discussions and negotiations with the Industrial Technologies Office of Industry Canada regarding the current and ongoing status, and possible modification, of a Contribution Agreement previously entered into by a predecessor of the client and Technology Partnerships Canada, represented by Her Majesty the Queen In Right of Canada relating to the development of recombinant protein vaccine technologies.